• Loading stock data...
Est. 2004

Wednesday 03/6/2019

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More


  • 1:12 PM

    NEW YORK, Nov. 14, 2017, PHIL, (GLOBE NEWSWIRE) — PHI Group, Inc., (www.phiglobal.com) (OTCQB:PHIL), a company focused on mergers and acquisitions and investments in selective industries, announced today that its wholly owned subsidiary Phivitae Corporation has signed a Business Cooperation Agreement with a Lao company to provide pharmaceutical products, medical equipment and healthcare supplies to Laos. According to the Agreement, Phivitae Corp. will be responsible for identifying and forming strategic alliance with reputable international manufacturers and suppliers in North America,

    Read more
  • 1:55 PM

    ORLANDO, Fla., Sept. 06, 2017, IMUN, (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing Lodonal™, its patented, affordable, non-toxic therapy for the management of cancer, HIV, autoimmune diseases and other inflammatory conditions, today announced that it has entered into an exclusive agreement with Kenya-based Omaera Pharmaceuticals, Ltd. for the sale and distribution of Lodonal™, valued at a minimum of $31 million in revenues over three years. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/d02d7135-cf47-471f-9fa0-17fa3e9728a7. Under the

    Read more
  • 1:34 PM

    NEW YORK, Aug. 28, 2017, PHIL, (GLOBE NEWSWIRE) — PHI Group, Inc., (www.phiglobal.com) (OTCQB:PHIL), a company focused on mergers and acquisitions and investments in natural resources, energy, agriculture, healthcare and special situations, announced today that it has formed PHIVITAE Corp., a Wyoming corporation, to serve as a holding subsidiary of the Company for pharmaceutical and healthcare-related business and signed a Letter of Intent (“LOI”) to acquire 80% of a 20-year old profitable European company that is engaged in pharmaceutical and

    Read more
  • 12:17 PM

    Aug 01, 2017, ETST, OTC Disclosure & News Service – Hollywood, FL, Aug. 01, 2017 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC PINK: ETST) (“ETST” or “the Company”), an innovative biotechnology company that operates in the fields of hemp cannabinoid, nutraceutical, pharmaceutical, and medical device research and development, announces that it has signed an agreement with the Centre de Développement Bioalimentaire du Québec (CDBQ), a major force in the agro-food industry in Canada. CDBQ to take ETST products from

    Read more
  • 12:04 PM

    Bend, OR, July 31, 2017, SGBY, (GLOBE NEWSWIRE) — Signal Bay, Inc. (OTCQB: SGBY) a leading provider of cannabis testing and advisory services announced today that its cannabis testing division EVIO Labs has licensed its first lab in Florida.    Kaycha Holdings, LLC will operate under the EVIO Labs brand and the lab will be managed by a lab director with over 18 years of experience in development of Nutraceutical and Pharmaceutical Products. CEO Mr. William Waldrop stated, “With operations in

    Read more
  • 1:49 PM

    NORTHVALE, N.J, Jan. 17, 2017, ELTP, (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP) today reported positive topline results from a pivotal bioequivalence fed study initiated in November 2016.  The topline results indicate that Elite’s generic product is bioequivalent to the branded product, OxyContin® (extended release Oxycodone Hydrochloride). A fasted study was previously conducted in September 2016, also with positive results. The study was a single dose crossover comparative bioavailability study of Oxycodone HCl extended release in

    Read more
Public Wire Banner